Fierce Pharma Biopharma News & Insights
Nov 4, 2024 · Fierce Pharma delivers breaking news and analysis about drug companies, the FDA and the broader pharma industry, including manufacturing, marketing and finance.
Top 20 pharma companies by 2023 revenue - Fierce Pharma
Apr 15, 2024 · J&J was No. 1 in 2023 by a comfortable margin over No. 2 Roche, which raked in sales of $58.7 billion Swiss francs ($67 billion) last year. J&J’s big lead is especially noteworthy considering ...
The top 20 drugs by worldwide sales in 2023 | Fierce Pharma
It's been several years since COVID-19 vaccines from Pfizer and Moderna jumped to the top of the pharma industry's sales charts, displacing longtime stalwarts with unprecedented sales. But, as ...
Pfizer is stepping up aid as Hurricane Milton threatens the US
Oct 8, 2024 · Pfizer—which opened a global hub in Tampa, Florida, in 2021—is setting out to bolster emergency services, pool donations and ease medical supply needs as Milton touches down this week, the ...
FDA found contamination issues at Thermo Fisher NC plant
Oct 11, 2024 · Thermo Fisher’s Greenville site also fills Wegovy injection pens after Novo tapped the manufacturer to help overcome its own shortage problems tied to FDA concerns at a Catalent plant. Thermo ...
The top 10 vaccine companies worldwide - Fierce Pharma
Oct 17, 2022 · Back in 2017, vaccine stalwarts like Merck, GSK and Sanofi led the list. Now, as industry watchers and others are aware, Pfizer is riding high atop the vaccines world. Throughout Pfizer's pandemic ...
FDA signs off on Regeneron and Sanofi's Dupixent for COPD
Sep 27, 2024 · The COPD nod will give an added boost to the already-booming sales of Dupixent, which generated $11.6 billion last year, a 33% increase from 2022. Analysts at Evercore ISI have projected that a ...
FDA signs off on Merck’s potential blockbuster Winrevair for PAH
Mar 26, 2024 · Analysts have estimated Winrevair's peak sales potential is at least $2 billion, with J.P. Morgan’s Chris Schott estimating it at $3 billion to $4 billion. J&J controlled half of the $7.3 ...
J&J cuts 231 at New Jersey headquarters; Bayer lops off 57 more …
Oct 1, 2024 · Big Pharma's layoff wave in New Jersey rolls on with hundreds of J&J cuts, 57 at Bayer. Johnson & Johnson is laying off 231 employees in New Jersey and Bayer is cutting 57 positions in the state ...
Battling Gilead, GSK shows real-world effectiveness of Apretude
Oct 16, 2024 · In two real-world evidence studies of nearly 1,300 people, Apretude has shown better than 99% effectiveness in preventing HIV infections. GSK’s ViiV Healthcare unit also presented findings from ...